Clinical Trials on Dental Fluorosis in Japan

Total 1524 results

Osaka City University

Unknown

Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease

Alzheimer's Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease

Alzheimer Disease

Japan
Avid Radiopharmaceuticals

Withdrawn

Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians

Alzheimer's Disease

Japan
Janssen Pharmaceutical K.K.

Completed

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease

Alzheimer's Disease

Japan
Avid Radiopharmaceuticals
Eli Lilly and Company

Completed

A Study of Florbetapir (18F) in Japanese Healthy Volunteers

Alzheimer's Disease

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531

Alzheimer Disease

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Safety and Efficacy of MT-4666

Alzheimer's Disease

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males

Healthy | Alzheimer Disease

Japan
Osamu Ukimura

Active, not recruiting

Targeted Cryoablation of Prostate Cancer Lesions: An Investigator-initiated Trial (PROCRY)

Prostate Cancer

Japan
Meiji Gakuin University

Recruiting

Group-based Acceptance and Commitment Therapy for Family Caregivers of People With Dementia in Japan

Dementia | Family Caregivers

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice

Alzheimer's Disease

Japan
Mitsubishi Tanabe Pharma Corporation

Terminated

Safety Study of MT-4666 in Subjects With Alzheimer's Disease

Alzheimer's Disease

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese Males

Alzheimer Disease

Japan
Mirai Iryo Research Center, Inc.

Completed

Intensive Instruction on the Use of Aricept

Alzheimer's Type Dementia

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease

Alzheimer's Desease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.

Alzheimer's Disease

Japan
Novartis Pharmaceuticals
Ono Pharmaceutical Co. Ltd

Completed

Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Japan
Janssen Pharmaceutical K.K.

Completed

Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia

Alzheimer's Disease

Japan
National Center of Neurology and Psychiatry, Japan

Terminated

Transcranial Direct Current Stimulation for Depression in Alzheimer's Disease Patient - Preliminary Research (ADAPT)

Depression | Alzheimer Disease

Japan
Avid Radiopharmaceuticals
Eli Lilly and Company

Completed

A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

Mild Cognitive Impairment | Alzheimer's Disease

Japan
Eisai Co., Ltd.

Completed

A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)

Lewy Body Disease | Dementia, Lewy Body

Japan
Translational Research Center for Medical Innovation...
Daiichi Sankyo Co., Ltd.

Completed

Exploratory Study for the Validity of QuQu Scale (QuQu)

Alzheimer Dementia

Japan
Kibi International University

Unknown

iPad Application-based Intervention for Post-stroke Depression

Post-stroke Depression

Japan
Osaka University
Kowa Company, Ltd.

Terminated

The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease (PIT-ROAD)

Alzheimer Disease | Hypercholesterolemia

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease

Alzheimer Disease

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects

Healthy | Alzheimer Disease

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).

Dementia With Lewy Body Disease

Japan
Translational Research Center for Medical Innovation...
Daiichi Sankyo Co., Ltd.

Completed

Verification Study and Reactivity Study for the Validity of QuQu Scale (QuQu)

Alzheimer's Disease Dementia | Cognitive Concern Without Dementia

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Agitation Associated With Dementia of the Alzheimer's Type

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Agitation Associated With Dementia of the Alzheimer's Type

Japan
GlaxoSmithKline

Completed

Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects

Depressive Disorder

Japan
GlaxoSmithKline

Completed

Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects

Depressive Disorder

Japan
Eisai Co., Ltd.

Recruiting

A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab

Alzheimer's Disease

Japan
Okayama University

Completed

Accurate Controlled Dental Sedation (ACDS)

Mental Retardation

Japan
Chugai Pharmaceutical

Completed

A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients

Alzheimer's Disease

Japan
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Alzheimer's Disease

Japan
Shionogi
Eli Lilly and Company

Terminated

A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder

Depressive Disorder

Japan
Nara Medical University

Completed

Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline

Hypertension | Brain Infarction

Japan
Okayama University

Completed

Effect of Valproate on Propofol

Mental Retardation

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses

Schizophrenia

Japan
Shionogi
Eli Lilly and Company

Completed

A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder

Depressive Disorder

Japan
Chiba University

Completed

An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia

Schizophrenia

Japan
Sumitomo Pharma Co., Ltd.

Completed

Long-term Study of DSP-5423P in Patients With Schizophrenia

Schizophrenia

Japan
Janssen Pharmaceutical K.K.

Completed

A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia

Schizophrenia

Japan
Osaka University

Completed

Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)

Dementia With Lewy Bodies (DLB)

Japan
MOA Health Science Foundation

Completed

Influence of Multi-dimensional Wellness Program on Quality of Life (MDWP)

Mental Disorders | Healthy | Physical Disorders

Japan
Kyoto University, Graduate School of Medicine
Philips Healthcare; Philips Respironics

Completed

The Effect of Adaptive Servo Ventilation and Oxygen Therapy in Central Sleep Apnea Patients

Sleep Apnea | Chronic Heart Failure

Japan
Otsuka Pharmaceutical Co., Ltd.

Terminated

Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Agitation Associated With Dementia of the Alzheimer's Type

Japan
Mochida Pharmaceutical Company, Ltd.
Pfizer

Completed

A Study of MD-120 in Patients With Depression

Major Depressive Disorder

Japan
Heptares Therapeutics Limited
Sosei

Withdrawn

A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies (DLB)

Dementia With Lewy Bodies

Japan

3

Subscribe